Potent neutralization of SARS‐CoV‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds
Abstract The persistence of the global severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic has brought to the forefront the need for safe and effective vaccination strategies. In particular, the emergence of several variants with greater infectivity and resistance to current vaccin...
Saved in:
Main Authors: | Peter J. Halfmann (Author), Ana Castro (Author), Kathryn Loeffler (Author), Steven J. Frey (Author), Shiho Chiba (Author), Yoshihiro Kawaoka (Author), Ravi S. Kane (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single immunization with an influenza hemagglutinin nanoparticle‐based vaccine elicits durable protective immunity
by: Shiho Chiba, et al.
Published: (2024) -
Improved Cancer Targeting by Multimerizing Aptamers on Nanoscaffolds
by: Marjan Omer, et al.
Published: (2020) -
Resolution of Eczema with Multivalent Peptides
by: Laura L. Eggink, et al.
Published: (2022) -
Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
by: Xingsu Gao, et al.
Published: (2022) -
Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain
by: Ping-Han Huang, et al.
Published: (2021)